A clinical trial of zosuquidar plus gemtuzumab ozogamicin (GO) in relapsed or refractory acute myeloid leukemia (RR AML): evidence of efficacy based on leukemic blast P-glycoprotein functional phenotype
Marcelletti, John F., Sikic, Branimir I.
Published in Cancer chemotherapy and pharmacology (01.11.2023)
Published in Cancer chemotherapy and pharmacology (01.11.2023)
Get full text
Journal Article
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype
Marcelletti, John F., Sikic, Branimir I.
Published in Cancer chemotherapy and pharmacology (01.06.2024)
Published in Cancer chemotherapy and pharmacology (01.06.2024)
Get full text
Journal Article
Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P‐glycoprotein modulation in acute myeloid leukemia
Marcelletti, John F., Sikic, Branimir I., Cripe, Larry D., Paietta, Elisabeth
Published in Cytometry. Part B, Clinical cytometry (01.01.2019)
Published in Cytometry. Part B, Clinical cytometry (01.01.2019)
Get full text
Journal Article
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia
Lancet, Jeffrey E, Baer, Maria R, Duran, George E, List, Alan F, Fielding, Robert, Marcelletti, John F, Multani, Pratik S, Sikic, Branimir I
Published in Leukemia research (01.08.2009)
Published in Leukemia research (01.08.2009)
Get full text
Journal Article
Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia
Marcelletti, John F, Multani, Pratik S, Lancet, Jeffrey E, Baer, Maria R, Sikic, Branimir I
Published in Leukemia research (01.06.2009)
Published in Leukemia research (01.06.2009)
Get full text
Journal Article
Assessment of serological markers associated with rheumatoid arthritis: Diagnostic autoantibodies and conventional disease activity markers
Marcelletti, John F, Nakamura, Robert M
Published in Clinical and Applied Immunology Reviews (01.09.2003)
Published in Clinical and Applied Immunology Reviews (01.09.2003)
Get full text
Book Review
Journal Article
Phase I/II Pharmacodynamic Study of the P-Glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Acute Myeloid Leukemia (AML)
Lancet, Jeffrey, Baer, Maria R., Cripe, Larry D., List, Alan F., Marcelletti, John F., Multani, Pratik S., Sikic, Branimir I.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Assessment of serological markers associated with rheumatoid arthritis
Marcelletti, John F, Nakamura, Robert M
Published in Clinical and applied immunology reviews (01.09.2003)
Published in Clinical and applied immunology reviews (01.09.2003)
Get full text
Journal Article
B-cell lymphokines and activation of the immune system by internal structures
del Guercio, Paolo, Marcelletti, John F, Katz, David H
Published in Immunology today (Amsterdam. Regular ed.) (01.04.1986)
Published in Immunology today (Amsterdam. Regular ed.) (01.04.1986)
Get full text
Journal Article
Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug
Pope, L E, Marcelletti, J F, Katz, L R, Katz, D H
Published in Journal of lipid research (01.10.1996)
Published in Journal of lipid research (01.10.1996)
Get full text
Journal Article